{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nutritional+and+Metabolic+Disease&page=6", "query": { "condition": "Nutritional and Metabolic Disease", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 17924, "total_pages": 1793, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nutritional+and+Metabolic+Disease&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Nutritional+and+Metabolic+Disease&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T09:16:25.179Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00044447", "title": "Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Non-Insulin-Dependent" ], "interventions": [ { "name": "Glimepiride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 170, "start_date": "2001-05", "completion_date": "2002-09", "has_results": false, "last_update_posted_date": "2008-06-19", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00044447" }, { "nct_id": "NCT01369147", "title": "The Energy Dose Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Critical Illness" ], "interventions": [ { "name": "Parenteral Nutrition", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Clevidipine", "type": "DRUG" }, { "name": "Dextrose-containing IV Fluids", "type": "DRUG" }, { "name": "Enteral feeding", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 12, "start_date": "2011-07", "completion_date": "2014-12-02", "has_results": true, "last_update_posted_date": "2022-06-10", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01369147" }, { "nct_id": "NCT01883258", "title": "Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "High intensity aerobic interval training", "type": "OTHER" }, { "name": "Continuous moderate intensity exercise", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "30 Years to 79 Years" }, "enrollment_count": 116, "start_date": "2013-05", "completion_date": "2018-07-16", "has_results": false, "last_update_posted_date": "2019-12-06", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01883258" }, { "nct_id": "NCT02034071", "title": "Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Prader-Willi Syndrome" ], "interventions": [ { "name": "DCCR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Essentialis, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "22 Years", "sex": "ALL", "summary": "10 Years to 22 Years" }, "enrollment_count": 13, "start_date": "2014-04", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02034071" }, { "nct_id": "NCT02341664", "title": "Patient and Provider Assessment of Lipid Management Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hyperlipidemia", "Hypercholesterolemia", "Cardiovascular Disease", "Diabetes", "Chronic Kidney Disease (CKD)", "Hypertension", "Smoking", "Myocardial Infarction (MI)", "Unstable Angina", "Angina", "Coronary Artery Disease (CAD)", "Stroke", "Transient Ischemic Attack (TIA)", "Carotid Stenosis", "Peripheral Arterial Disease", "Atherosclerosis", "Claudication" ], "interventions": [], "intervention_types": [], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7658, "start_date": "2015-05", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2020-03-02", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • San Pedro, California • Ventura, California + 11 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Pedro", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Hialeah Gardens", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02341664" }, { "nct_id": "NCT01464099", "title": "Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "insulin aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2008-06", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01464099" }, { "nct_id": "NCT00661999", "title": "Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia", "Leukemia", "Lymphoma", "Lymphoproliferative Disorder", "Multiple Myeloma and Plasma Cell Neoplasm", "Precancerous Condition", "Unspecified Adult Solid Tumor, Protocol Specific" ], "interventions": [ { "name": "darbepoetin alfa", "type": "BIOLOGICAL" }, { "name": "ferrous sulfate", "type": "DIETARY_SUPPLEMENT" }, { "name": "sodium ferric gluconate complex in sucrose", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DIETARY_SUPPLEMENT", "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 502, "start_date": "2006-01", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2011-05-17", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 2, "location_summary": "Scottsdale, Arizona • Rochester, Minnesota", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00661999" }, { "nct_id": "NCT00002016", "title": "A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cytomegalovirus Retinitis", "HIV Infections" ], "interventions": [ { "name": "Sevirumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sandoz", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 2, "location_summary": "Boston, Massachusetts • Galveston, Texas", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002016" }, { "nct_id": "NCT01029704", "title": "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus Type 2" ], "interventions": [ { "name": "EGT0001442", "type": "DRUG" }, { "name": "Placebo capsules to match EGT0001442", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Theracos", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 151, "start_date": "2009-12", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2021-06-16", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 9, "location_summary": "Birmingham, Alabama • National City, California • Denver, Colorado + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "National City", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01029704" }, { "nct_id": "NCT01218204", "title": "A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidaemias", "Dyslipidemias" ], "interventions": [ { "name": "10mg atorvastatin", "type": "DRUG" }, { "name": "80mg atorvastatin", "type": "DRUG" }, { "name": "GSK1292263 Placebo", "type": "DRUG" }, { "name": "100mg GSK1292263", "type": "DRUG" }, { "name": "300mg GSK1292263", "type": "DRUG" }, { "name": "800mg GSK1292263", "type": "DRUG" }, { "name": "10mg ezetimibe", "type": "DRUG" }, { "name": "Washout", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 287, "start_date": "2010-09-14", "completion_date": "2011-06-29", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-10-14T09:16:25.179Z", "location_count": 21, "location_summary": "Anniston, Alabama • Chula Vista, California • Stockton, California + 15 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01218204" } ] }